MDxHealth has joined forces with Ghent University to establish NXTGNT, a pharmacoepigenomics center.
The center’s mission is to accelerate innovation in personalized medicine by using advanced technology, knowledge, and expertise in epigenetics. The center will bring together scientific expertise from disease-centered basic researchers, corresponding clinical validation teams, bioinformaticians, and epigenomic technology focused on the discovery of effective individualized epigenetic-based diagnostic and personalized therapeutic products.
The center is located at Ghent University within the pharmaceutical biotechnology lab. The facility will house MDxHealth’s research team and lab equipment for development of epigenetic tests together with the Ghent University team for (epi)genetic sequencing.
MDxHealth, 949-812-6979